In this study, a target gene of miR-1/194/206-3p was MFAP4, which was recently identified as a biomarker for hepatic fibrosis and has been used to detect high-risk patients with severe fibrosis stages among hepatitis C patients48. Here, MFAP4 is linked to hepatitis C virus infection.